Stockholders’ Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 11, 2023 |
Jul. 06, 2023 |
Mar. 16, 2023 |
Feb. 09, 2023 |
Jan. 23, 2023 |
Jul. 31, 2022 |
Jun. 30, 2022 |
May 31, 2022 |
Apr. 30, 2022 |
Mar. 22, 2022 |
Jan. 29, 2021 |
Dec. 31, 2023 |
Jul. 24, 2023 |
Jul. 23, 2023 |
Oct. 26, 2022 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Dec. 31, 2022 |
Oct. 31, 2023 |
Jul. 11, 2023 |
Dec. 31, 2018 |
|
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Common stock, authorized | 116,666,667 | 116,666,667 | 116,666,667 | ||||||||||||||||||||
| Common stock par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||
| Common stock, shares issued | 55,184,623 | 55,184,623 | 44,108,661 | ||||||||||||||||||||
| Common stock, shares outstanding | 55,184,623 | 55,184,623 | 44,108,661 | ||||||||||||||||||||
| Preferred stock shares | 10,000,000 | 10,000,000 | 10,000,000 | ||||||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||
| Preferred stock, authorized | 5,000,000 | 5,000,000 | 5,000,000 | ||||||||||||||||||||
| Certificate of designation series A preferred stock | 5,000,000 | 5,000,000 | |||||||||||||||||||||
| Preferred stock, shares issued | |||||||||||||||||||||||
| Preferred stock, shares outstanding | |||||||||||||||||||||||
| Registration statement amount (in Dollars) | $ 150,000,000 | ||||||||||||||||||||||
| Sales amount (in Dollars) | $ 50,000,000 | ||||||||||||||||||||||
| Percentage of gross proceeds | 3.00% | 13.00% | |||||||||||||||||||||
| ATM shares | 11,995 | 337,859 | 171,775 | 343,045 | |||||||||||||||||||
| Average price per share (in Dollars per share) | $ 5.62 | $ 7.12 | $ 7.19 | $ 7.49 | $ 1.5 | $ 1.5 | |||||||||||||||||
| Net proceeds (in Dollars) | $ 650,000 | $ 2,360,000 | $ 1,200,000 | $ 2,500,000 | |||||||||||||||||||
| Compensation paid (in Dollars) | $ 1,844 | $ 110,428 | $ 37,242 | $ 77,421 | |||||||||||||||||||
| Offering costs (in Dollars) | $ 0 | $ 0 | $ 145,293 | ||||||||||||||||||||
| Share of common stock | 1,984,918 | 7,431,610 | 7,148,447 | ||||||||||||||||||||
| Outstanding interest (in Dollars) | $ 164,053 | ||||||||||||||||||||||
| Warrants outstanding to purchase an aggregate | 2,374,208 | 586,440 | 7,825,792 | 1,901,802 | |||||||||||||||||||
| Options term | 7 years 5 months 19 days | ||||||||||||||||||||||
| Exercise price per share (in Dollars per share) | $ 0.89 | ||||||||||||||||||||||
| Issued share | 2,329,444 | 2,329,444 | |||||||||||||||||||||
| Stock options to purchase common stock description | On January 23, 2023, in connection with the acquisition of Airobotics, the Company granted stock options to purchase 1,064,946 shares of Common Stock, of which 773,244 options were vested and the remaining 291,702 vest monthly through November 13, 2025. The vested options have a weighted average contractual remaining life of approximately 6.08 years, an exercise price ranging from $0.49 to $12.35 per share, resulting in a weighted average exercise price of $5.43 per share, and a grant date fair value ranging from $0 to $1.48 per share. The unvested options have a weighted average contractual remaining life of approximately 7.52 years, an exercise price ranging from $0.49 to $24.70 per share, resulting in a weighted average exercise price of $15.80 per share, and a grant date fair value ranging from $0 to $1.45 per share. | On January 23, 2023, in connection with the acquisition of Airobotics, the Company granted stock options to purchase 1,064,946 shares of Common Stock, of which 773,244 options were vested and the remaining 291,702 vest monthly through November 13, 2025. The vested options have a weighted average contractual remaining life of approximately 6.08 years, an exercise price ranging from $0.49 to $12.35 per share, resulting in a weighted average exercise price of $5.43 per share, and a grant date fair value ranging from $0 to $1.48 per share. The unvested options have a weighted average contractual remaining life of approximately 7.52 years, an exercise price ranging from $0.49 to $24.70 per share, resulting in a weighted average exercise price of $15.80 per share, and a grant date fair value ranging from $0 to $1.45 per share. | |||||||||||||||||||||
| Aggregate stock option | 1,793,000 | 317,625 | |||||||||||||||||||||
| Purchase of common stock (in Dollars) | $ 10,090 | $ 701 | $ 64,909 | ||||||||||||||||||||
| Compensation expense related to non-vested options (in Dollars) | $ 2,026,874 | ||||||||||||||||||||||
| Weighted-average period | 2 years 10 months 9 days | ||||||||||||||||||||||
| Restricted stock units shares | 3,000 | ||||||||||||||||||||||
| Restricted stock description | The restricted stock units vest as follows: 20% on September 13, 2023, 40% on January 10, 2024, and 40% on February 21, 2024 and are contingent on continuing employment. | ||||||||||||||||||||||
| Restricted stock | 180,000 | 99,574 | |||||||||||||||||||||
| Stock-based compensation expense (in Dollars) | $ 2,800,000 | $ 2,800,000 | |||||||||||||||||||||
| Equity Incentive Plan [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Common stock reserved for issuance | 6,000,000 | 6,000,000 | 3,333,334 | ||||||||||||||||||||
| Minimum [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Common stock, authorized | 116,666,667 | ||||||||||||||||||||||
| Aggregate offering price (in Dollars) | $ 40,000,000 | ||||||||||||||||||||||
| Range percentage | 0.00% | ||||||||||||||||||||||
| Minimum [Member] | Equity Incentive Plan [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Common stock, authorized | 6,000,000 | ||||||||||||||||||||||
| Maximum [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Common stock, authorized | 300,000,000 | ||||||||||||||||||||||
| Aggregate offering price (in Dollars) | $ 50,000,000 | ||||||||||||||||||||||
| Range percentage | 100.00% | ||||||||||||||||||||||
| Maximum [Member] | Equity Incentive Plan [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Common stock, authorized | 8,000,000 | ||||||||||||||||||||||
| Stock Option [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Aggregate stock option | 21,940 | 1,539 | |||||||||||||||||||||
| Purchase of common stock (in Dollars) | $ 31,250 | ||||||||||||||||||||||
| Equity Incentive Plan [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Issued share | 1,052,373 | ||||||||||||||||||||||
| ATM Agreement [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Offering costs (in Dollars) | $ 151,431 | ||||||||||||||||||||||
| Warrant [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 9.95 | $ 2.22 | $ 2.22 | ||||||||||||||||||||
| Warrants issued | 12,566,092 | 12,566,092 | |||||||||||||||||||||
| Weighted-average contractual remaining life | 4 years 11 months 15 days | ||||||||||||||||||||||
| Warrant [Member] | Minimum [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | 9.26 | $ 0.03 | $ 0.03 | ||||||||||||||||||||
| Warrant [Member] | Maximum [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | 12.35 | 12.35 | |||||||||||||||||||||
| Warrant [Member] | Securities Purchase Agreement [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 7.63 | ||||||||||||||||||||||
| Warrant [Member] | Securities Purchase Agreement [Member] | Minimum [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | 0.03 | ||||||||||||||||||||||
| Warrant [Member] | Securities Purchase Agreement [Member] | Maximum [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | 7.89 | ||||||||||||||||||||||
| Series A Preferred Stock | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||
| Preferred stock, authorized | 5,000,000 | 5,000,000 | 5,000,000 | ||||||||||||||||||||
| Preferred stock, shares issued | |||||||||||||||||||||||
| Preferred stock, shares outstanding | |||||||||||||||||||||||
| Warrant [Member] | Maximum [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 12.35 | ||||||||||||||||||||||
| Forecast [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Stock option vested | 6,250 | ||||||||||||||||||||||
| Vested shares | 25,000 | ||||||||||||||||||||||
| Restricted Stock Units [Member] | |||||||||||||||||||||||
| Stockholders’ Equity [Line Items] | |||||||||||||||||||||||
| Restricted stock units shares | 66,000 | ||||||||||||||||||||||